niacin/laropiprant

DRUG3 trials

Sponsors

University Medical Centre Ljubljana, Instituto Aragones de Ciencias de la Salud, Calmy Alexandra

Conditions

AtherosclerosisCoronary Heart DiseaseHIVHypercholesterolemia

Phase 4

Niacin/Laropiprant and Endothelial Function

CompletedNCT01126073

University Medical Centre LjubljanaCoronary Heart Disease

Start: 2010-09-30End: 2011-10-31Target: 60Updated: 2011-10-06

Effect of Niacin in the Lipoprotein (a) Concentration

CompletedNCT01321034

Instituto Aragones de Ciencias de la SaludHypercholesterolemia

Start: 2011-10-31End: 2012-12-31Updated: 2013-01-10

ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART

TerminatedNCT01683656

Calmy AlexandraAtherosclerosis, HIV

Start: 2012-08-31End: 2014-07-31Updated: 2019-10-08